Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.24.2.u1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2024
Dec. 31, 2023
Current assets    
Cash and cash equivalents $ 97,920 $ 125,492
Marketable securities 19,767 2,979
Restricted cash 3,559  
Accounts receivable, net 36,037 42,241
Inventories, net 24,048 21,840
Income tax receivable 1,050 669
Prepaid expenses and other current assets 12,410 13,846
Total current assets 194,791 207,067
Property and equipment, net 47,022 50,316
Goodwill 9,764 10,057
Intangible assets, net 33,585 34,591
Operating lease right-of-use asset 19,951 20,338
Other assets 3,806 3,825
Total assets 308,919 326,194
Current liabilities    
Accounts payable and accrued expenses 26,783 30,142
Accrued payroll 13,746 11,066
Warranty reserve - current 9,759 9,628
Operating lease liability - current 3,332 3,653
Earnout liability 11,180 10,000
Deferred revenue - current 7,385 7,980
Income tax payable   27
Total current liabilities 72,185 72,496
Long-term liabilities    
Warranty reserve - noncurrent 15,897 13,850
Operating lease liability - noncurrent 18,106 18,270
Deferred revenue - noncurrent 7,066 8,227
Deferred tax liability 8,070 8,539
Total liabilities 121,324 121,382
Commitments and contingencies (Note 10)
Stockholders' equity    
Common stock, $0.001 par value per share; 200,000,000 authorized; 23,718,774 and 23,324,750 shares issued and outstanding as of June 30, 2024 and December 31, 2023, respectively 24 23
Additional paid-in capital 324,826 320,513
Accumulated deficit (137,117) (116,949)
Accumulated other comprehensive income (loss) (138) 1,225
Total stockholders' equity 187,595 204,812
Total liabilities and stockholders' equity $ 308,919 $ 326,194